查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1234362

呼吸道融合細胞病毒(RSV)診斷的全球市場-成長，未來展望，競爭分析(2023年～2031年)

Respiratory Syncytial Virus (RSV) Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球呼吸道融合細胞病毒(RSV)診斷的市場規模，預計至2030年以9.5％的年複合成長率成長。RSV感染疾病的高發生率，對特異性迅速且高感度的診斷技術的未滿足需求，RSV感染疾病的患者數增加，促進市場成長。

本報告提供全球呼吸道融合細胞病毒(RSV)診斷市場相關調查分析，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
    • 報告的目的
    • 目標受眾
    • 主要的產品
  • 市場區隔
  • 調查手法
    • 階段Ⅰ-2次調查
    • 階段Ⅱ-1次調查
    • 階段Ⅲ-專家的審查
    • 假設
    • 所採用的方法

第2章 摘要整理

  • 市場概述:全球呼吸道融合細胞病毒(RSV)診斷市場
  • 全球呼吸道融合細胞病毒(RSV)診斷市場(100萬美元)(2021年):各診斷技術
  • 全球呼吸道融合細胞病毒(RSV)診斷市場(100萬美元)(2021年):各終端用戶
  • 全球呼吸道融合細胞病毒(RSV)診斷市場(100萬美元)(2021年):各地區
  • 富有魅力的投資提案(2021年):各地區

第3章 呼吸道融合細胞病毒(RSV)診斷市場:競爭分析

  • 主要的呼吸道融合細胞病毒(RSV)診斷市場供應商的市場定位
  • 呼吸道融合細胞病毒(RSV)診斷市場供應商採用的策略
  • 主要的產業策略
  • 階層分析:2021年和2030年的比較

第4章 呼吸道融合細胞病毒(RSV)診斷市場:常量分析和市場動態

  • 簡介
  • 全球呼吸道融合細胞病毒(RSV)診斷市場金額(100萬美元)(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • See-Saw分析

第5章 呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年):各診斷技術

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 分子診斷學
    • 免疫學的檢驗
    • 單株抗體
    • 流式細胞技術
    • 影像診斷
    • 層析法
    • 微小凝膠粒子
    • 其他技術(光散射分析，微脂體等)

第6章 呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年):各終端用戶

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 醫院
    • 護養設施
    • 商業研究所
    • 公共衛生研究所

第7章 北美的呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年)

第8章 英國及歐洲聯盟的呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年)

第9章 亞太地區的呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年)

第10章 南美的呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年)

第11章 中東及非洲的呼吸道融合細胞病毒(RSV)診斷市場，美金(100萬)(2020年～2030年)

第12章 企業簡介

  • Abbott Laboratories, Inc.
  • bioMerieux SA
  • Becton
  • Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • EMD Millipore
  • Thermo Fisher Scientific, Inc.
  • 其他
Product Code: 138149-01-23

Respiratory Syncytial Virus (RSV) Diagnostics Market Expected to Grow at 9.5% by 2030. Respiratory Syncytial Virus (RSV) is a single-stranded RNA virus that causes respiratory infections such as pneumonia, bronchiolitis and among others. In tropical climates, RSV infection is more prominent during the rainy season. RSV infections cause a considerable burden on the global economy due to the high infection rate. According to the Centers for Disease Control and Prevention, an approximate of 150,000 hospitalizations (on average) are a result of RSV infections each year in the United States. The high incidence of the RSV infection, and unmet need for specific, rapid, and sensitive diagnostic techniques are the prime factors accounting for the RSV diagnostics market growth.

The global RSV diagnostics market is categorized based on the diagnostic technologies, end-users, and geography. Based on the diagnostic technology types, the global market is segmented into molecular diagnostics, immunoassays, monoclonal antibodies, flow cytometry, diagnostic imaging, chromatography, gel microdroplets, and other technologies. Among these, molecular diagnostics have higher specificity and sensitivity that accounts for the higher preference. Thus, in 2021, the molecular diagnostics segment dominated the global RSV diagnostics market.

Based on end-users, the global market is dominated by hospitals segmented owing to the high patient visits with RSV infection. However, the commercial health laboratories have gained attention in last few years and expected to be one of the fastest growing segment during the forecast period.

North America dominated the global RSV diagnostics market in 2021 owing to the rising patient pool with RSV infections and technological advancements in point-of-care molecular diagnostic devices. According to the data published by the Centers for Disease Control and Prevention (CDC), around 50,000 deaths were reported in 2012 due to pneumonia in the United States. Furthermore, Asia Pacific is identified to surge at fastest rate during the forecast period. High prevalence of bronchitis and pneumonia in this region accounted for the fastest growth during the forecast period.

Key market players hold the major market share and the rest of the market is occupied by the local players. The key players adopted certain organic and inorganic strategies to penetrate into the market. For instance, Abbott received US FDA clearance and CLIA waiver for its Alere Reader Lateral Flow Assay Analyzer and Alere i RSV Rapid Molecular Test in 2016. Furthermore, after the establishment of Abbott diagnostics division in India (2016), the company acquired Alere Medical (U.S.) in 2017. Such strategies are further adopted by other key players accounting for market growth.

RSV Diagnostics Market Dynamics

Drivers

Increasing Burden of RSV Infections

Growing Demand for Point-Of-Care Molecular Diagnostic Tests for the Diagnosis of RSV Infections

Increasing Adoption of Molecular Diagnostics Over Immunoassays

Increasing Approval of RSV Diagnostic Kits and Assays

Restraint

Low Detection Limits of Immunoassays

Opportunities

Technological Advancements in Diagnostic Methods

Threats

Development of RSV Vaccines

Key Players Identified in RSV Diagnostics Market include:

Abbott Laboratories, Inc., bioMerieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., EMD Millipore, Thermo Fisher Scientific, Inc. And Others.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Respiratory Syncytial Virus (RSV) Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Respiratory Syncytial Virus (RSV) Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Diagnostic Technology

Molecular Diagnostics

Immunoassays

Monoclonal Antibodies

Flow Cytometry

Diagnostic Imaging

Chromatography

Gel Microdroplets

Other Technologies (Differential Light Scattering, Liposomes etc.)

End-users

Hospitals

Nursing Homes

Commercial Laboratories

Public Health Laboratories

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Respiratory Syncytial Virus (RSV) Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Respiratory Syncytial Virus (RSV) Diagnostics market?

Which is the largest regional market for Respiratory Syncytial Virus (RSV) Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Respiratory Syncytial Virus (RSV) Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Respiratory Syncytial Virus (RSV) Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Respiratory Syncytial Virus (RSV) Diagnostics Market
  • 2.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Diagnostic Technology, 2021 (US$ Million)
  • 2.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End-users, 2021 (US$ Million)
  • 2.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Respiratory Syncytial Virus (RSV) Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Respiratory Syncytial Virus (RSV) Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Respiratory Syncytial Virus (RSV) Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Respiratory Syncytial Virus (RSV) Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Molecular Diagnostics
    • 5.3.2. Immunoassays
    • 5.3.3. Monoclonal Antibodies
    • 5.3.4. Flow Cytometry
    • 5.3.5. Diagnostic Imaging
    • 5.3.6. Chromatography
    • 5.3.7. Gel Microdroplets
    • 5.3.8. Other Technologies (Differential Light Scattering, Liposomes etc.)

6. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Hospitals
    • 6.3.2. Nursing Homes
    • 6.3.3. Commercial Laboratories
    • 6.3.4. Public Health Laboratories

7. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
  • 7.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
  • 7.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 7.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 7.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 7.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)

8. UK and European Union Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
  • 8.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
  • 8.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 8.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 8.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 8.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 8.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 8.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 8.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)

9. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
  • 9.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
  • 9.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 9.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 9.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 9.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 9.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 9.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 9.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)

10. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
  • 10.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
  • 10.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 10.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 10.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 10.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)

11. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
  • 11.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
  • 11.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 11.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 11.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
        • 11.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. bioMerieux SA
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Becton
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Dickinson and Company
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Bio-Rad Laboratories, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. EMD Millipore
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Thermo Fisher Scientific, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Others
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 3 North America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 4 North America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 5 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 6 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 7 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 8 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 13 UK Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 14 UK Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 15 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 16 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 17 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 18 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 19 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 20 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 21 France Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 22 France Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 25 Asia Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 26 Asia Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 27 China Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 28 China Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 29 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 30 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 31 India Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 32 India Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 33 Australia Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 34 Australia Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 35 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 36 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 37 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 38 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 39 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 40 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 41 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 42 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 47 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 48 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 49 Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 50 Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Quality Assurance
  • FIG. 5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Diagnostic Technology, 2021
  • FIG. 6 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End-users, 2021
  • FIG. 7 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Respiratory Syncytial Virus (RSV) Diagnostics Market, 2021
  • FIG. 9 Market Positioning of Key Respiratory Syncytial Virus (RSV) Diagnostics Market Players, 2021
  • FIG. 10 Global Respiratory Syncytial Virus (RSV) Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Diagnostic Technology, 2021 Vs 2030, %
  • FIG. 12 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End-users, 2021 Vs 2030, %
  • FIG. 13 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 20 France Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 22 China Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 24 India Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030